Co-founder of Avisi Technologies named one of the Greater Philadelphia’s Inno Under 25
Applaud Medical wins FDA breakthrough device designation for urinary stone deviceAlong with co-founder Brandon Kao, Rui Jing Jiang started Avisi Technologies in 2017, developing VisiPlate, a nanotechnology-enabled ocular implant to treat glaucoma. The University of Pennsylvania spinout has raised more... Read More →
Naluri: The Digital Health Tech Company Of The Future
Digital health tech company Naluri gives you remote digital health monitoring and expert advice in the palm of your hands. When it comes to the digital transformation of healthcare, one area deserves particular attention in this age of discovery: health... Read More →
Bluegrass Vascular Announces Decision by Medicare to Assign a New Technology Ambulatory Payment Classification (APC) for the Surfacer® System Procedure
The new code is C9780, Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance. Read More →
Rhaeos, Inc. Awarded $4 Million NIH SBIR Grant to Expand Quantitative Measurement Capabilities of its FlowSense™ Noninvasive Wireless Sensor
Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program through the National Institute of Neurological Disorders and Stroke (NINDS). Read More →
FDA Clears Fully Automated Cardiac Ultrasound Solution to Measure 2D and Doppler
Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated decision support tool for echocardiography. Read More →
Vertigo Treatment Receives FDA Breakthrough Device Designation, featuring Otolith Labs
Otolith Labs, launched at the Halcyon Incubator, has received U.S. Food and Drug Administration (FDA) Breakthrough Device designation for its medical device that is designed to be prescribed by physicians for the treatment of vertigo. Read More →
Automated lung sound analysis using the LungPass platform: a sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19
Lower respiratory tract (LRT) involvement, observed in about 20% of patients suffering from coronavirus disease 2019 (COVID-19), is associated with a more severe clinical course, adverse outcomes, and long-term sequelae [1, 2]. Read More →
Madorra wins FDA breakthrough nod for home vulvovaginal atrophy treatment device
Madorra this week said it has received FDA breakthrough device designation for its noninvasive, home-use device for moderate to severe vulvovaginal atrophy. Read More →
Nutromics won in the category of ‘Technology Platform Solution of the Year’ at the AIIA’s 2021 national iAwards!
We are excited to announce that last night Nutromics won in the category of 'Technology Platform Solution of the Year' at the AIIA's 2021 national iAwards! Read More →
InBrace Raises $102M Series D Financing
InBrace, the orthodontic company behind the novel Smartwire™ category of behind-the-teeth, teeth straightening, today announced the closing of an oversubscribed $102 million Series D financing by funds affiliated with new investor groups co-led by Farallon Capital Management, L.L.C. and Marshall Wace. Read More →